Generally mild injection-site reactions, flushing, headache, water retention
How it works: GHRH receptor agonism (CJC-1295): binds pituitary somatotrophs via the GHRH receptor, amplifying baseline GH pulse amplitude and duration over the course of days due to albumin binding Ghrelin receptor agonism (Ipamorelin): activates GHS-R1a with an earlier onset and more immediate GH secretion spike compared to GHRH analogs, providing a complementary time profile Sequential synergy: the two peptides act on distinct receptor systems and exhibit a combined GH output greater than either alone, with ipamorelin providing the acute peak and CJC-1295 sustaining elevated trough levels IGF-1 elevation: downstream GH signaling raises circulating IGF-1, the primary mediator of tissue repair, protein synthesis, and connective tissue remodeling
Megaloblastic Anemia
And, you know, it's not to say that everyone needs peptides, right
Unlike growth factors, which act via receptor-specific pathways, BPC-157 and TB-500 function through intracellular signaling modulation and cytoskeletal regulation
Table 2 SORT recommendations for clinical practice